Article Listing - Genmab antibodies showing promise say analysts; profitable by 2006?

FDA MOVE UPGRADES BIOCRAFT EARNINGS

9 March 1992

Biocraft stock has been upgraded from a hold to a buy on the news that the US Food and Drug...

EC GO-AHEAD FOR DRUG PATENT EXTENSION

9 March 1992

The Council of Ministers of the Commission of the European Community has adopted, as expected, a common position on the...

POLAND REIMPOSES DUTY ON IMPORTS

9 March 1992

The Polish Customs Office has introduced a 10% duty on drugs and medicines brought into the country from abroad, to...

FRENCH GOVT HEALTH COST DEAL

9 March 1992

The government of France appears at last to be prepared to endorse a new agreement on medical fees and drug...

BIOCRAFT LABS MAKES 3rd QTR LOSS

9 March 1992

US concern Biocraft Laboratories made sales for the third quarter ended December 31, 1991, of $24.2 million, up 16.7% on...

PFIZER IN JAPANESE ACQUISITION

9 March 1992

US pharmaceutical concern Pfizer has acquired all outstanding shares of Koshin Medical KK, a medical equipment wholesaler in Japan,...

FORTHCOMING MEETINGS

9 March 1992

Among Management Forum's meetings to be held in London in March are Over-The-Counter Medicines (Conf No E3-17), March 24 and...

EC SINGLE MARKET "HYPE" WARNING

9 March 1992

Hans Ruediger Vogel, the director of the German drug industry association, the BPI, has warned against excessive expectations from the...

MERCK AFFIRMS SAFETY of MEVACOR

9 March 1992

Following recent reports that HMG-CoA reductase inhibitor products may have serious side effects, a spokeswoman for Merck has told the...

APPOINTMENTS AT MMD

9 March 1992

At Marion Merrell Dow: Linda Hogan becomes director of licensing; Kevin Hartley named director of taxes; Jill Goodman to...

Showing 94671-94680 of 95316 articles

Go to beginningPreviousNextGo to end